Contact
Please use this form to send email to PR contact of this press release:
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
TO:
Please use this form to send email to PR contact of this press release:
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
TO: